Advanced search
Publication Cover
Journal of Investigative Surgery Volume 23, 2010 - Issue 3
Submit an article Journal homepage
72
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Prognostic Significance of Neuroepithelial Transforming Protein 1 in Hepatocellular Carcinoma

Ke YeDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
, MD,
Zhiming WangDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, ChinaCorrespondence[email protected]
, MD,
Gewen ZhangDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
, MD &
Shuai LiangDepartment of General Surgery, Xiangya Hospital, Central South University, Changsha, Hunan, China
, MS
Pages 163-169 | Received 05 Dec 2009, Accepted 18 Mar 2010, Published online: 30 Jun 2010

REFERENCES

  • Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006;6:674–687.
  • Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet. 2002;31:339–346.
  • Symons M, Rusk N. Control of vesicular trafficking by Rho GTPases. Curr Biol. 2003;13:R409–R418.
  • Rossman KL, Der CJ, Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol. 2005;6:167–180.
  • Ishak KG, Anthony PP, Sobin LH. Nonepithelial tumors. In: Histological Typing of Tumors of the Liver. World Health Organization International Classification of Tumors. Ishak KG, ed. Berlin: Springer; 1994:22–27.
  • Wittekind C. Pitfalls in the classification of liver tumors. Pathologe. 2006;27:289–293.
  • Gao Q, Qiu SJ, Fan J, Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007;25:2586–2593.
  • Zhu XD, Zhang JB, Zhuang PY, High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol. 2008;26:2707–2716.
  • Li Chen, Zhiwei Wang, Xi Zhan, Association of NET-1 gene expression with human hepatocellular carcinoma. Int J Surg Pathol. 2007;15:346–353.
  • Serru V, Dessen P, Boucheix C, Sequence and expression of seven new tetraspans. Biochim Biophys Acta. 2000;1478:159–163.
  • Zhu YY, Machleder EM, Chenchik A, Reverse transcriptase template switching: a SMART approach for full-length cDNA library construction. Biotechniques. 2001;30:892–897.
  • Wollscheid V, Kuhne-Heid R, Stein I, Identification of a new proliferation-associated protein net-1/c4-8 characteristic for a subset of high-grade cervical intraepithelial neoplasia and cervical carcinoma. Int J Cancer. 2002;99:771–775.
  • Qin H, Carr HS, Wu X, Characterization of the biochemical and transforming properties of the neuroepithelial transforming protein 1. J Biol Chem. 2005;280:7603–7613.
  • Shen S-Q, Li K, Zhu N, Expression and clinical significance of NET-1 and PCNA in hepatocellular carcinoma. Med Oncol. 2008;25:341–345.
  • Ihou XO. Recurrence and metastasis of hepatocellular carcinoma: progress and prospects. Hepatobiliary Pancreat Dis Int. 2002;1:35–41.
  • Miyasaka Y, Enomoto N, Nagayama K, Analysis of differentially expressed genes in human hepatocellular carcinoma using suppression subtractive hybridization. Br J Cancer. 2001;85:228–234.
  • Serru V, Dessen P, Boucheix C, Sequence and expression of seven new tetraspans. Biochim Biophys Acta. 2000;1478:159–163.
  • Xu J, Stolk JA, Zhang X, Identification of differentially expressed genes in human prostatic cancer using subtraction and microarray. Cancer Res. 2000;60:1677–1682.
  • Leyden J, Murray D, Moss A, Net1 and Myeov: computationally identified mediators of gastric cancer. Br J Cancer. 2006;94:1204–1212.
  • Utsunomiya T, Doki Y, Takemoto H, Correlation of betacatenin and cyclin D1 expression in colon cancers. Oncology 2001;61:226–233.
  • Pan HW, Chou HY, Liu SH, Role of L2DTL, cell cycle-regulated nuclear and centrosome protein, in aggressive hepatocellular carcinoma. Cell Cycle 2006;5:2676–2687.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.